P53 is required for Doxorubicin-induced apoptosis via the TGF-beta signaling pathway in osteosarcoma-derived cells | |
Sun, Yifu; Xia, Peng; Zhang, Haipeng; Liu, Biao; Shi, Ying | |
刊名 | AMERICAN JOURNAL OF CANCER RESEARCH
![]() |
2016 | |
卷号 | 6期号:1 |
关键词 | Osteosarcoma P53 doxorubicin chemotherapy TGF-beta signaling pathway |
ISSN号 | 2156-6976 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3541764 |
专题 | 吉林大学白求恩第一医院 |
推荐引用方式 GB/T 7714 | Sun, Yifu,Xia, Peng,Zhang, Haipeng,et al. P53 is required for Doxorubicin-induced apoptosis via the TGF-beta signaling pathway in osteosarcoma-derived cells[J]. AMERICAN JOURNAL OF CANCER RESEARCH,2016,6(1). |
APA | Sun, Yifu,Xia, Peng,Zhang, Haipeng,Liu, Biao,&Shi, Ying.(2016).P53 is required for Doxorubicin-induced apoptosis via the TGF-beta signaling pathway in osteosarcoma-derived cells.AMERICAN JOURNAL OF CANCER RESEARCH,6(1). |
MLA | Sun, Yifu,et al."P53 is required for Doxorubicin-induced apoptosis via the TGF-beta signaling pathway in osteosarcoma-derived cells".AMERICAN JOURNAL OF CANCER RESEARCH 6.1(2016). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论